CNG Hero

Early intervention in major diseases

Empowering neurological health

The Clinical Neuroscience Group (CNG) is hosted by the Department of Neurology, Akershus University Hospital (Ahus) in collaboration with the University of Oslo (UiO). Our expressed goal is to focusour research on common diseases of the nervous system, with large impacts on individual health and societal costs.

Our aim is to improve the standard ofcare with knowledge from the edge of research.

Learn more about CNG

Fields of interests

The Clinical Neuroscience Group (CNG) is hosted by the Department of Neurology, Akershus University Hospital in collaboration with the University of Oslo. Our expressed goal is to focus our research on common diseases of the nervous system, with large impacts on individual health and societal costs.

To achieve this, the group has focused on four main fields of interest:

Read more

In the media

Get overview related articles in the media regarding Clinical Neuroscience Group.

See all
CNG Hero

Early intervention in diseases

Recent Publications

See all publications

Sleep duration and cognitive function, The Akershus Cardiac Examination 1950 Study.

PubMed↗
Ihle-Hansen H, Einvik G, Hagberg G, … , Ihle-Hansen H
...
July 24, 2024

Costs of diagnosing early Alzheimer's disease in three European memory clinic settings: Results from the precision medicine in Alzheimer's disease project

PubMed↗
Wimo A, Kirsebom BE, Timón-Reina S, … , Fladby T
...
July 18, 2024

Physical Activity, Fitness, and Long-Term Risk of Amyotrophic Lateral Sclerosis: A Prospective Cohort Study

PubMed↗
Vaage AM, Meyer HE, Landgraff IK, … , Nakken O
...
June 26, 2024
CNG Hero

Societal Contribution

Members of CNG and CNG as a whole contribute to multiple aspects for society locally, nationally and internationally. We work to disseminate our knowledge gained from research.

Read more
CNG Hero

Collaboration—Network

In the field of multiple sclerosis and ALS we have a long standing collaboration with partners at Haukeland University hospital and NeuroSysMed for partnerships in clinical studies and access to the national MS Registry.

Read more